AstraZeneca to invest $2 billion in the U.S. post Trump's win. Amedisys stock drops due to UnitedHealth acquisition lawsuit. Johnson & Johnson challenges federal health agency. Novavax shares fall despite revenue beat.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
